Global Regulation And Shifting Norms Will Curtail Prospects

Key Takeaways

• Aggressive regulation, shifting consumer attitudes, and ESG-driven divestment are pressuring BAT's traditional revenue streams, valuation, and long-term profitability.
  
• Exposure to emerging markets heightens volatility, while illicit competition and bans constrain diversification beyond legacy tobacco products.
  
• Innovation-driven growth in alternative products, margin expansion, regulatory improvements, and cost-saving programs are strengthening revenue stability, cash flow, and future earnings potential.

Catalysts

Provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States.

• Accelerating global regulation and legislative restrictions on both combustible and next-generation tobacco products are expected to further limit BAT's ability to grow volumes and raise prices, undermining long-term revenue and tightening group-level net margins even as the company pushes into new markets and categories.
  
• Shifting consumer behavior and growing cultural aversion to nicotine usage, combined with the global rise of wellness and health consciousness, are likely to drive persistent declines in traditional cigarette sales and present sustained structural pressure on BAT's core revenue streams despite temporary gains from smokeless products.
  
• The rapid adoption of ESG criteria among institutional investors and continued divestment from tobacco-related stocks threatens to depress BAT's valuation, increase its cost of capital, and constrain its ability to maintain elevated shareholder returns via dividends and buybacks over the long-term.
  
• BAT's heavy reliance on combustible sales in developing and emerging markets exposes the company to heightened currency and geopolitical risks, with volatile earnings and translation headwinds likely to erode reported profits and limit the long-term stabilization of margins and adjusted EPS.
  
• Intensifying regulatory scrutiny and outright bans on vaping and heated tobacco products, combined with the rise of illicit and counterfeit alternatives and the emergence of non-nicotine recreational substances, are set to impede future growth in new categories and restrict revenue diversification opportunities, ultimately threatening BAT's capacity to offset long-run declines in its legacy business.

British American Tobacco Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• This narrative explores a more pessimistic perspective on British American Tobacco compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
• The bearish analysts are assuming British American Tobacco's revenue will grow by 3.2% annually over the next 3 years.
• The bearish analysts assume that profit margins will shrink from 30.0% today to 25.8% in 3 years time.
• The bearish analysts expect earnings to reach £7.3 billion (and earnings per share of £3.51) by about June 2029, down from £7.7 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as £9.0 billion.
• In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 14.6x on those 2029 earnings, up from 12.9x today. This future PE is greater than the current PE for the US Tobacco industry at 12.5x.
• The bearish analysts expect the number of shares outstanding to decline by 0.94% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.75%, as per the Simply Wall St company report.

Risks

• Robust growth in BAT's Modern Oral and Heated Products, driven by successful innovation (Velo Plus, glo Hilo), is accelerating revenue diversification and contributing to margin expansion, making top line and operating profit less dependent on declining combustibles and supporting earnings stability.
  
• BAT's scale, brand portfolio strength, and channel execution in the U.S. and key emerging markets are enabling the company to offset volume declines in traditional cigarettes with price/mix improvements, stabilizing revenue and underpinning strong free cash flow.
  
• Regulatory enforcement is improving at the state and federal level in the U.S. and select markets, targeting illicit vape products, which could restore competitiveness and drive recovery in legal vapour category sales, positively impacting revenue and profit in future periods.
  
• Operational efficiency programs such as 'Fit2Win' and cost of goods savings initiatives are on track to generate multi-billion pound savings, which will structurally enhance net margins while enabling continued investment in product innovation and growth.
  
• Consistent high free cash flow generation, strong shareholder returns through progressive dividends and share buybacks, and potential asset divestitures (ITC Hotels stake) provide capital allocation flexibility and help underpin above-average growth in earnings per share.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The assumed bearish price target for British American Tobacco is £39.07, which represents up to two standard deviations below the consensus price target of £50.45. This valuation is based on what can be assumed as the expectations of British American Tobacco's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
• However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of £57.5, and the most bearish reporting a price target of just £36.0.
• In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be £28.1 billion, earnings will come to £7.3 billion, and it would be trading on a PE ratio of 14.6x, assuming you use a discount rate of 8.8%.
• Given the current share price of £45.91, the analyst price target of £39.07 is 17.5% lower.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.